Inicure has been awarded support from the INCATE network (Incubator for Antibacterial Therapies in Europe). Access to advice and the network of partners, including industry and health providers, will truly support and boost our work to combat drug-resistant bacterial infections.
The EIC-Transition proposal — iCURE “Novel small molecule FPR1 agonists for treating antibiotic-resistant and chronic bacterial infections” coordinated by Inicure and submitted together with our partners at Swansea University, Queen Mary University of London and LIOS received very high ranking in the competitive evaluation process. Although the project was eventually not granted, we are super proud to have received the Seal of Excellence by the European Commission!